BalneotherapyBalneotherapy's Impact on Inflammation and Quality of Life in Knee Osteoarthritis
Balneotherapy
+ home exercise program
Arthritis+3
+ Joint Diseases
+ Musculoskeletal Diseases
Treatment Study
Summary
Study start date: July 1, 2025
Actual date on which the first participant was enrolled.The study aims to explore the effects of balneotherapy, which involves treatments using mineral-rich water, on knee osteoarthritis. Specifically, the research focuses on how this therapy might reduce inflammation and improve quality of life for adults aged 50 to 80 who have moderate to severe knee osteoarthritis. This condition often leads to joint pain and stiffness, and the study seeks to understand if balneotherapy can lower harmful substances in the blood that contribute to inflammation and joint damage. By potentially reducing these markers, the treatment could offer a new way to manage symptoms and slow disease progression, providing a valuable option for those affected by this common and often painful condition. Participants in the study are randomly divided into two groups. One group receives balneotherapy sessions at a thermal center for 15 to 20 minutes each morning, five days a week, over three weeks. The other group follows a home exercise routine and uses pain relief medication like paracetamol. Both groups receive educational material on managing knee osteoarthritis. The study measures changes in specific blood markers before and after treatment to assess the effects of the therapies. Statistical tests will help determine if there are significant differences between the groups, offering insights into the potential benefits of balneotherapy for knee osteoarthritis.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.50 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Study Objectives
Primary Objectives
Secondary Objectives